Emory Department of Medicine continued to navigate difficult times and adjust to a new normal during the ongoing COVID-19 pandemic this year. Despite the challenges, our faculty, staff, and trainees excelled and contributed greatly to each of our mission areas.

Most notably, our department played a crucial role in clinical trials for leading COVID-19 vaccines and therapeutics, which has resulted in millions of protected Americans, reduced hospitalizations, and the continued decline of positive COVID-19 cases.

While more challenges lie ahead, we are immensely proud of the entire department’s efforts in 2021 and we are confident in the great work to come in 2022.

Take a look back at some of the many challenges, accomplishments, and honors of the past year, below.

COVID-19 Reflections and News

To view more DOM research news from this year, visit Emory News Center.

Health Equity Day

The Department of Medicine’s RYSE Diversity, Equity, and Inclusion Council hosted the inaugural Health Equity Day May 11, 2021. The department-wide event aimed to raise awareness and encourage action around the systemic health disparities that exist across racial, ethnic, cultural, and social groups. The event also recognized interventions and research across the department centered on health equity.

Health Equity Day earned two Phoenix Awards and an Award of Excellence from the Georgia Chapter of the Public Relations Society of America (PRSA).

Emory ranks fifth among U.S. universities for infectious diseases program

Emory University’s infectious diseases program ranks fifth in the U.S. and ninth in the world, according to U.S. News & World Report. From HIV to Ebola to COVID-19, Emory has led the way in tackling deadly diseases. Click here to read more in the Emory News Center.